Home
Search

BIO Early-Stage Resources Hub

Access a range of exclusive resources, including cost-saving programs, educational webinars and stay up-to-date with the latest BIO Emerging Companies Section (ECS) events with our comprehensive resource center, designed to empower early-stage companies and help them thrive.

SBIR
Raising Investor Capital
Capital Formation Policy Issues
Industry Analysis
BIO Office Hour Materials
Tax Policy Issues
SBIR (4)
ECS Digital Resources
View All
Showing 1 - 4 of 4
PDF
SBIR Application Key Decision Points Flowchart
FLIP
A grant application flowchart from start to finish. Includes decision points and scenarios to help determine which agencies and grants to apply to.
DOWNLOAD PDF
VIEW PDF
FLIP
PDF
BIO Office Hours: Grant Writing Slides
FLIP
A PowerPoint presentation on the grant application process. An overview of how to identify opportunities, how to compose a proposal, and project management tips.
DOWNLOAD PDF
VIEW PDF
FLIP
PDF
PSC Biotech: Grant Writing White Paper
FLIP
A white paper on regulatory grant writing, best practices for developing proposals, success factors, and tackling grant writing challenges.
DOWNLOAD PDF
VIEW PDF
FLIP
PDF
Grant Application Timeline
FLIP
A three-month schedule for completing an SBIR/STTR grant application including key activities to complete.
DOWNLOAD PDF
VIEW PDF
FLIP
Raising Investor Capital (2)
ECS Digital Resources
View All
Showing 1 - 2 of 2
PDF
BIO Large Biopharma Therapeutic Focus Guide
FLIP
This resource provides guidance to assist early-stage companies in identifying potential large biopharma partners.
DOWNLOAD PDF
VIEW PDF
FLIP
PDF
BIO Large Biopharma Therapeutic Focus Resource
FLIP
This resource provides guidance to assist early-stage companies in identifying potential large biopharma partners.
DOWNLOAD PDF
VIEW PDF
FLIP
Capital Formation Policy Issues (15)
ECS Digital Resources
View All
Showing 1 - 4 of 15
PDF
SEC Comment Letter: Request for Comment on Climate Risk Disclosures (6/13/2021)
FLIP
Comments on SEC request for information on climate risk disclosures.
DOWNLOAD PDF
VIEW PDF
FLIP
PDF
BIO Issue Brief: Committee on Foreign Investment in the United States (CFIUS) (9/22/2022)
FLIP
An overview of CFIUS and how the Administration’s focus on protecting the U.S. Biotech Industry could cause unintentional harm by impeding foreign investment and collaborations.
DOWNLOAD PDF
VIEW PDF
FLIP
PDF
FTC Comment Letter: Request for Information on Merger Enforcement (4/15/2022)
FLIP
Comments to FTC on merger enforcement.
DOWNLOAD PDF
VIEW PDF
FLIP
PDF
SEC Comment Letter: Short Position and Short Activity Reporting (4/25/2022)
FLIP
Comments on proposed rule to require money managers to disclose within 14 calendar days after month-end certain gross short positions on companies.
DOWNLOAD PDF
VIEW PDF
FLIP
PDF
Testimony: "The Impact of Consolidation and Monopoly Power on American Innovation" (12/15/2021)
FLIP
Testimony of BIO’s Chief Policy Officer before the Senate Subcommittee on Competition Policy, Antitrust, and Consumer Rights on consolidation and monopoly power.
DOWNLOAD PDF
VIEW PDF
FLIP
PDF
Request for Comment on Proposed Amendments to Rules Governing Proxy Voting Advice (12/23/2021)
FLIP
Comments on proposed rule governing proxy voting advice.
DOWNLOAD PDF
VIEW PDF
FLIP
PDF
BIO Letter to Senate Banking Cmte: Proposals to Foster Capital Formation and Economic Growth in the Bioeconomy (3/18/2021)
FLIP
BIO Letter to Senate Banking Committee in support of proposals to foster capital formation for biotechs.
DOWNLOAD PDF
VIEW PDF
FLIP
PDF
Cybersecurity Risk Management, Strategy, Governance, and Incident Disclosure (5/5/2022)
FLIP
Comments on proposed rule to enhance and standardize disclosures regarding cybersecurity risk management, strategy, governance, and incident reporting by public companies.
DOWNLOAD PDF
VIEW PDF
FLIP
PDF
FTC Comment Letter: Business Practices of Pharmacy Benefit Managers and Their Impact on Independent Pharmacies and Consumers (5/5/2022)
FLIP
Comments in response to FTC Solicitation for Public Comments on the Business Practices of Pharmacy Benefit Managers and Their Impact on Independent Pharmacies and Consumers.
DOWNLOAD PDF
VIEW PDF
FLIP
PDF
Minimum Pricing Increments, Access Fees, and Transparency of Better Priced Orders (3/30/2023)
FLIP
Comments on proposed rule to adapt a variable minimum pricing increments for the quoting and trading of NMS stocks, reduce access fee caps, and enhance transparency of better priced orders.
DOWNLOAD PDF
VIEW PDF
FLIP
PDF
BIO Letter of Support: Short Sale Transparency and Market Fairness Act (7/29/2021)
FLIP
BIO Support of H.R. 4618, to amend short sale reporting requirements.
DOWNLOAD PDF
VIEW PDF
FLIP
SEE MORE
Industry Analysis (4)
ECS Digital Resources
View All
Showing 1 - 4 of 4
PDF
The State of Innovation in Antibacterial Therapeutics
FLIP
This report investigates recent investment into antibacterial innovation and the current clinical pipeline that will help bridge the gaps in the antibacterial armamentarium.
DOWNLOAD PDF
VIEW PDF
FLIP
PDF
The State of Innovation in Vaccines and Prophylactic Antibodies for Infectious Diseases
FLIP
This report focuses on vaccine innovation and success at the clinical stage, as well as the innovation of prophylactic antibodies in clinical trials.
DOWNLOAD PDF
VIEW PDF
FLIP
PDF
IRA’s Impact on the US Biopharma Ecosystem
FLIP
New research released by Vital Transformation (VT) shows that the Inflation Reduction Act (IRA) will stifle the ability of companies to continue research and development across a broad range of therapeutic areas.
DOWNLOAD PDF
VIEW PDF
FLIP
PDF
Emerging Therapeutic Company Investment and Deal Trends
FLIP
New BIO Industry Analysis trend data have been released for Emerging Therapeutic Company Investment, R&D-Stage Out-licensing, and Acquisitions.
DOWNLOAD PDF
VIEW PDF
FLIP
BIO Office Hour Materials (1)
ECS Digital Resources
View All
Showing 1 of 1
PDF
Chubb Cyber Index
FLIP
Contains graphs and charts on cyber threat trends. View data on assets affected, annual claims, and more by industry and revenue size.
DOWNLOAD PDF
VIEW PDF
FLIP
Tax Policy Issues (5)
ECS Digital Resources
View All
Showing 1 - 4 of 5
PDF
BIO Tax Priorities Overview (7/6/2023)
FLIP
An overview of BIO’s tax policy priorities.
DOWNLOAD PDF
VIEW PDF
FLIP
PDF
Letter to House & Senate Leaders: R&D Amortization (5/4/2023)
FLIP
BIO and BIO members urge immediate legislative action to repeal the harmful R&D amortization provision that went into effect in 2022.
DOWNLOAD PDF
VIEW PDF
FLIP
PDF
Talking Points: Impact of Domestic R&D Amortization on the Biotechnology Community (4/21/2023)
FLIP
Talking points on the background, impact on the biotechnology community and solution.
DOWNLOAD PDF
VIEW PDF
FLIP
PDF
Letter to House & Senate Leaders: R&D Amortization (6/15/2022)
FLIP
BIO, BIO members, and State affiliates urge immediate legislative action to repeal the harmful R&D amortization provision that went into effect in 2022.
DOWNLOAD PDF
VIEW PDF
FLIP
PDF
Statement for the Record: "American Ingenuity: Promoting Innovation Through the Tax Code"
FLIP
BIO letter to House Small Business Committee outlining 7 tax policy recommendations for supporting biotechs.
DOWNLOAD PDF
VIEW PDF
FLIP